Using cognitive-behavioral therapy for insomnia in cancer clinics
Implementation of a Stepped Care Cognitive-Behavioral Therapy for Insomnia in Routine Cancer Care
This study is testing an online therapy program for insomnia to see if it helps cancer patients sleep better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | CHU de Quebec-Universite Laval Academic / other |
| Locations | 1 site (Québec) |
| Trial ID | NCT04817163 on ClinicalTrials.gov |
What this trial studies
This study aims to implement a web-based cognitive-behavioral therapy for insomnia (CBT-I) specifically designed for cancer patients, who often experience high rates of insomnia. The approach includes a self-administered treatment that can be accessed online, followed by professionally-administered booster sessions to enhance effectiveness. By utilizing a stepped care model, patients will receive the level of intervention they need based on their individual circumstances. This method seeks to improve access to effective insomnia treatment for cancer patients, addressing a significant unmet need in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with non-metastatic cancer and can read and understand English or French.
Not a fit: Patients with severe cognitive impairments or psychological comorbidities requiring clinical attention may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve sleep quality and overall well-being for cancer patients suffering from insomnia.
How similar studies have performed: Other studies have shown success with cognitive-behavioral therapy for insomnia in various populations, suggesting a promising potential for this approach in cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * have received a diagnosis of non-metastatic cancer (any type) * to be aged 18 years and older * to be readily able to read and understand French or English * having the minimum cognitive abilities to read, understand and memorize information * having access to Internet Exclusion Criteria: * having a psychological comorbidity needing clinical attention (e.g., major depressive disorder) * having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia) * having insomnia due to a temporary condition (e.g., acute pain, short-term medication side effects, environmental factors)
Where this trial is running
Québec
- Centre de recherche de L'Hôtel-Dieu de Québec — Québec, Canada (Recruiting)
Study contacts
- Principal investigator: Josée Savard, Ph.D. — Centre de recherche du CHU de Québec-Université Laval
- Study coordinator: Josée Savard, Ph.D.
- Email: josee.savard@psy.ulaval.ca
- Phone: 418-525-4444
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.